Bank of New York Mellon’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10
| Closed | -$9K | – | 4587 |
|
|
2022
Q2 | $9K | Sell |
10
-10
| -50% | -$9K | ﹤0.01% | 4555 |
|
|
2022
Q1 | $50K | Hold |
20
| – | – | ﹤0.01% | 4520 |
|
|
2021
Q4 | $52K | Buy |
+20
| New | +$52K | ﹤0.01% | 4493 |
|
|
2021
Q2 | – | Sell |
-22
| Closed | -$161K | – | 4448 |
|
|
2021
Q1 | $161K | Hold |
22
| – | – | ﹤0.01% | 4097 |
|
|
2020
Q4 | $181K | Hold |
22
| – | – | ﹤0.01% | 3998 |
|
|
2020
Q3 | $228K | Sell |
22
-22
| -50% | -$228K | ﹤0.01% | 3804 |
|
|
2020
Q2 | $293K | Buy |
44
+10
| +29% | +$66.6K | ﹤0.01% | 3694 |
|
|
2020
Q1 | $154K | Hold |
34
| – | – | ﹤0.01% | 3798 |
|
|
2019
Q4 | $206K | Buy |
34
+17
| +100% | +$103K | ﹤0.01% | 3905 |
|
|
2019
Q3 | $120K | Hold |
17
| – | – | ﹤0.01% | 3990 |
|
|
2019
Q2 | $111K | Hold |
17
| – | – | ﹤0.01% | 4005 |
|
|
2019
Q1 | $141K | Buy |
17
+5
| +42% | +$41.5K | ﹤0.01% | 3947 |
|
|
2018
Q4 | $67K | Hold |
12
| – | – | ﹤0.01% | 4017 |
|
|
2018
Q3 | $106K | Hold |
12
| – | – | ﹤0.01% | 4021 |
|
|
2018
Q2 | $102K | Hold |
12
| – | – | ﹤0.01% | 3989 |
|
|
2018
Q1 | $62K | Hold |
12
| – | – | ﹤0.01% | 4127 |
|
|
2017
Q4 | $62K | Hold |
12
| – | – | ﹤0.01% | 4157 |
|
|
2017
Q3 | $130K | Hold |
12
| – | – | ﹤0.01% | 3957 |
|
|
2017
Q2 | $103K | Buy |
12
+1
| +9% | +$8.58K | ﹤0.01% | 4021 |
|
|
2017
Q1 | $101K | Buy |
+11
| New | +$101K | ﹤0.01% | 4024 |
|